AMN Healthcare Services, Inc. (AMN) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary indicates stable financial health with strategic debt refinancing, positive market trends, and optimistic guidance. The Q&A section supports this with strong growth expectations and effective handling of strike events. Despite some unclear responses, the overall sentiment is positive due to potential margin growth, healthy business pipeline, and strategic market positioning.
Key Financial Performance
Full Year 2025 Revenue $2.73 billion, a year-over-year decrease of 8%. The decline was attributed to a decrease in demand across various segments.
Full Year 2025 Adjusted EBITDA $234 million, a decrease of 31% year-over-year. This was due to lower revenue and a decline in gross margin.
Debt Reduction in 2025 $285 million. This reduction was part of the company's efforts to improve its financial position.
Fourth Quarter 2025 Revenue $748 million, 2% higher than the year-ago quarter and $18 million above the high end of guidance. The increase was driven by labor disruption revenue.
Labor Disruption Revenue in Q4 2025 $124 million, nearly doubled compared to the year-ago quarter. This was due to two large labor disruption events.
Nurse and Allied Revenue in Q4 2025 $491 million, an 8% year-over-year increase. Excluding labor disruption, the segment revenue was down 7% year-over-year, but improved from a 13% decline in the third quarter.
Physician and Leadership Solutions Revenue in Q4 2025 $170 million, down 2% year-over-year. The decline was attributed to seasonality and disruptions in demand.
Technology and Workforce Solutions Revenue in Q4 2025 $88 million, down 18% year-over-year or 14% excluding the divested Smart Square business. The decline was due to adverse revenue mix and lower margins in Language Services.
Gross Margin for Q4 2025 26.1%, a decline of 370 basis points year-over-year. The reduction was influenced by labor disruption revenue, which reduced gross margin by 130 basis points.
Adjusted EBITDA for Q4 2025 $54 million, down 27% year-over-year. The decline was due to lower gross margins and increased SG&A expenses.
Net Loss for Q4 2025 $8 million, compared to a net loss of $188 million in the prior year period. The prior year's loss included a non-cash goodwill impairment charge.
Adjusted Earnings Per Share for Q4 2025 $0.22, compared to $0.75 in the prior year period. The decline was due to lower adjusted EBITDA.
Operating Cash Flow for Q4 2025 $76 million. This was supported by a reduction in days sales outstanding.
Full Year 2025 Gross Margin 28.3%, a decrease of 250 basis points from the prior year. The decline was due to adverse revenue mix and lower margins in certain segments.
Full Year 2025 Adjusted Earnings Per Share $1.36, compared to $3.31 in the prior year. The decline was due to lower adjusted EBITDA and gross margins.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Language Services Expansion: Investing in AI technology to support administrative and nonclinical interactions with patients, expanding capabilities to support broader client choices.
VMS Enhancements: Deployed advanced analytics, generative AI, and expanded support for internal float pool and agency management.
Labor Disruption Revenue: Generated $124 million in Q4 2025, nearly double the previous year, with $600 million expected in Q1 2026 from multiple strike events.
Market Share Gains: Positioned to gain share in direct and vendor-neutral segments, leveraging AI-enabled recruiting and workforce management solutions.
Debt Reduction: Reduced debt by $285 million in 2025.
Operational Efficiency: Automated and tech-enabled business processes to handle higher demand, improving speed to fill and onboarding capabilities.
Strategic Partnerships: Focused on building long-term partnerships with clients for workforce management and labor disruption support.
Growth Transition: 2026 identified as a transition year to return all businesses to growth, targeting sustainable organic revenue growth of 4%-6% annually post-2026.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Labor Disruption Events: The company is experiencing significant labor disruption events, which, while driving revenue, are reducing consolidated gross margins and increasing operational costs. These events require additional resources and create operational challenges.
Decline in Technology and Workforce Solutions Revenue: Revenue in this segment decreased by 18% year-over-year, with specific declines in Language Services and VMS revenue. This decline is attributed to adverse revenue mix shifts, lower margins, and the sale of Smart Square.
Physician and Leadership Solutions Revenue Decline: Revenue in this segment decreased by 2% year-over-year, with locum tenens and interim leadership showing declines. Seasonal demand declines and client disruptions due to strike events are contributing factors.
Increased SG&A Expenses: Sequential increases in SG&A expenses are driven by unfavorable professional liability actuarial adjustments, increased bad debt expenses, and additional costs to support labor disruption events.
Gross Margin Decline: Consolidated gross margin declined by 370 basis points year-over-year, impacted by lower labor disruption margins and adverse revenue mix shifts.
Economic and Market Pressures: The healthcare labor market is showing signs of normalization, but clients are increasingly seeking cost-effective solutions, which may pressure pricing and margins.
Dependence on Labor Disruption Revenue: A significant portion of revenue is derived from labor disruption events, which are unpredictable and may not be sustainable long-term.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Nurse and Allied Revenue: Expected to increase by more than 135% year-over-year in Q1 2026, or 2% to 4% year-over-year excluding labor disruption, and 4% to 6% sequentially from Q4 2025.
Physician and Leadership Revenue: Projected to decline by 5% to 8% year-over-year in Q1 2026, with interim leadership down mid-single digits, search flat to up, and locums down mid-single digits year-over-year. Sequential growth expected in the middle quarters of 2026.
Technology and Workforce Solutions Revenue: Anticipated to decline in the mid- to upper teens year-over-year in Q1 2026, or low teens excluding Smart Square. Language Services revenue expected to be modestly lower sequentially.
Labor Disruption Revenue: Assumed to be $600 million in Q1 2026 from multiple strike events, reducing consolidated gross margin but driving operating leverage.
Language Services: Expected to see gross margin benefits in the second half of 2026 from a tiered service strategy addressing price competition. Anticipated return to year-over-year revenue growth later in 2026.
Consolidated Revenue Growth Post-2026: Excluding labor disruption, sustainable organic revenue growth of 4% to 6% per year is projected, with operating expenses growing at half the rate of revenue growth, leading to 10% to 15% adjusted EBITDA growth.
Market Trends and Strategic Positioning: Healthcare labor market conditions are normalizing in 2026, with clients increasingly adopting blended labor models and centralizing contingent labor spend. AMN is positioned to support these trends and gain market share.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Do you have separate operating procedures or sales force for labor disruption business to ensure it doesn't disrupt the rest of your business?
A:The company has developed and invested in technology and an operating model over the past 2 years to support strike events. They have a dedicated strike team, including sales, leadership, and operations roles, with resources from across the company and external sources. They have a playbook for seamless resource integration and training. While there has been some marginal impact on core business, the system has worked well given the magnitude of events.
Q:What are the risks of AI disrupting your language translation business, and how are you countering them?
A:The language service business is focused on clinical healthcare settings, which by government regulation requires a human interface. The company uses tech-enabled capabilities but ensures compliance with federal laws through human interpreters. AI is being used to enhance technology connecting patients to interpreters and to improve the patient journey outside clinical settings. There is no indication of clients wanting to replace human interpreters with AI in clinical settings.
Q:Are the nurses involved in the $600 million incremental revenue from labor disruption known to you, and can they be used for future assignments?
A:The supply includes crisis workers known to the company, new workers, and suppliers. Some clinicians are travelers or per diem workers, while others focus on labor disruption events. The company has achieved high fill rates and used AI recruiters to recruit faster. Relationships with these clinicians provide opportunities for future assignments, including labor disruption events or other roles.
Q:Is there any update on the Kaiser contract, and could it be reworked early?
A:The contract with Kaiser runs through the end of the year, and the company expects an RFP as part of Kaiser's normal governance process. The company has a strong, long-standing partnership with Kaiser.
Q:Does the advancement in the March Visa Bulletin change the outlook for the international staffing business in 2026?
A:The latest visa bulletin advanced dates more than expected, which is positive for the international staffing business. The company expects mid-teens growth in 2026 from international staffing, a higher-margin business. This advancement will help particularly at the end of the year going into 2027.
Q:Does the labor pool for strike disruption crowd out the ability to staff other projects?
A:The company has built its strike support system to enable simultaneous support for core clients. Transparency ensures clinicians are not pulled from core clients. The company continues to see strong support for the core business, and the strike events have not meaningfully impacted the ability to staff core clients.
Q:How does pricing affect fill rates for strike and non-strike business?
A:Orders priced correctly get filled quickly. In strike situations, pricing is transparent and adjusted to fill workforce needs rapidly. In non-strike business, clients may adjust pricing over time to fill orders. The company educates clients on pricing flexibility to meet demand.
Q:What is the potential for AI disruption in your business, and how are you responding?
A:AI disruption is not a concern for the language services business due to government regulations requiring human interpreters. Pricing pressure in the business is due to competitive dynamics, not AI. The company is piloting a new service model to address competition and sees AI as accretive for productivity and operational improvements.
Q:What is the margin guidance for Q1, excluding strike business?
A:Excluding the $600 million strike revenue, the revenue range is $625 million to $640 million. Gross margin excluding strike is around 26.8% to 27%, slightly down from Q4. Adjusted SG&A is expected to be in the $130 million to $135 million range, with underlying adjusted EBITDA similar to Q4.
Q:What are the long-term growth expectations for each segment, and what factors could influence them?
A:The company expects 4% to 6% organic growth on the top line beyond this year, with all segments growing within this range. Recovery in year-over-year growth is expected in 2026, with normalized demand for healthcare consumption driving growth. Operating leverage and investments in AI and operational improvements will support double-digit EBITDA growth.
Q:What are the seasonal patterns expected for the balance of the year?
A:Nurse and Allied segments typically see a sequential decline in Q2 due to the end of winter orders and school-related declines in Allied. Physician and Leadership segments usually grow in Q2, driven by locum tenens and interim search. Language Services is expected to improve in Q2 due to new contracts and better performance. Overall, excluding strike, Q2 is expected to be relatively flat.
Q:How should we interpret the $600 million strike revenue guidance?
A:The $600 million guidance is based on current visibility and does not predict the duration of strikes. Revenue per day calculations are not straightforward due to the dynamic nature of strikes, including changes in union member participation.
Q:What is the relationship between contingent travel nurse bill rates and full-time nurse compensation?
A:Contingent labor is becoming more attractive due to cost parity with full-time nurses and the added flexibility it offers. The company expects increases in bill rates in 2026 to reflect natural wage growth, which will support contingent labor demand.
Q:Are there any reputational or legislative risks associated with supporting strike events?
A:Supporting strike events is seen as an important service for clients and continuity of care. It enables unions to strike legally by ensuring patient care. The company views this as enhancing its ability to offer diverse roles to clinicians and does not foresee reputational or legislative risks.
Q:What are the cash flow expectations for 2026, and how does CapEx compare to 2025?
A:CapEx for 2026 is expected to be in the low to mid-$40 million range, similar to 2025. Free cash flow to EBITDA conversion is expected to normalize to 60%-65% over two years, with 2026 seeing a working capital drag compared to 2025. The company has paid off its revolver and aims to reduce leverage below 3x.
Q:What is the pipeline for new business in Nurse and Allied segments?
A:The pipeline is healthy and balanced, with opportunities in both MSP and vendor-neutral models. The company has seen wins in both areas and continues to focus on direct opportunities and cross-selling to existing clients. Conversion of the pipeline has been strong.
Q:How does the company view the long-term 4%-6% growth target?
A:The company considers the 4%-6% growth target reasonable, accounting for external factors and economic changes. It aims to exceed this target through market share gains and operational improvements, while maintaining a prudent approach to long-term expectations.
Q:Review of Unclear Management Responses
A:Management avoided providing a clear answer on the potential upside or downside of the $600 million strike revenue guidance if strikes continue or end earlier than expected. They also used vague language when discussing the dynamic nature of strike events, making it difficult to calculate revenue per day or predict future impacts.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI enablement
AI support
AI technology
AMN demand
AMN partner
AMN term
Agentic AI
Allied International
Allied labor
Allied staffing
Clients labor
Full replay
Healthcare Full
Smart Square
assumption
client event
disruption Allied
disruption demand
disruption event
disruption support
driver
event labor
interaction
investment
labor disruption
language service
margin end
model
momentum
need labor
patient
return
segment labor
strike event
supplier
teen
term partner
value
AMN Transcript
AMN Healthcare Services, Inc. (AMN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Neutral6-8
AMN Healthcare Services, Inc. (AMN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Neutral5-14
AMN Healthcare Services, Inc. (AMN) Q1 2026 Earnings Call Transcript
Unknown5-13
The earnings call reveals a decline in revenue and EPS, with net income also down due to increased expenses. Despite improved gross margin and operating cash flow, the lack of strategic updates and forward-looking statements raises concerns about future growth. Given the market cap, the stock is likely to react negatively to these results.
AMN Healthcare Services, Inc. (AMN) Q4 2025 Earnings Call Transcript
Positive2-19
The earnings call summary indicates stable financial health with strategic debt refinancing, positive market trends, and optimistic guidance. The Q&A section supports this with strong growth expectations and effective handling of strike events. Despite some unclear responses, the overall sentiment is positive due to potential margin growth, healthy business pipeline, and strategic market positioning.
AMN Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
